The role of neuropeptides in adverse myocardial remodeling and heart failure

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cellular and Molecular Life Sciences

• Publication date

  2017-01-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00018-017-2452-xPMID 28097372PMCID PMC6339818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

  2016cited by this paper
• Chronic Administration of Catestatin Improves Autonomic Function and Exerts Cardioprotective Effects in Myocardial Infarction Rats

  2016cited by this paper
• Thyroid hormones and cardiac remodeling

  2016cited by this paper
• The predictive value of plasma catestatin for all-cause and cardiac deaths in chronic heart failure patients.

  2016cited by this paper
• TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

  2016cited by this paper
• Molecular and cellular neurocardiology: development, and cellular and molecular adaptations to heart disease

  2016cited by this paper
• Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance

  2016cited by this paper
• Role of substance P in the cardiovascular system.

  2016cited by this paper
• Thyroid Disease and the Heart.

  2016cited by this paper
• Thyroid hormones and the heart

  2016cited by this paper
• Plasma Catestatin in Patients with Acute Coronary Syndrome

  2016cited by this paper
• Low levels of plasma galanin in obese subjects with hypertension

  2016cited by this paper
• Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress

  2015cited by this paper
• Emerging Novel Therapies for Heart Failure

  2015cited by this paper
• Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling.

  2015cited by this paper
• Catestatin Exerts Direct Protective Effects on Rat Cardiomyocytes Undergoing Ischemia/Reperfusion by Stimulating PI3K-Akt-GSK3β Pathway and Preserving Mitochondrial Membrane Potential

  2015cited by this paper
• The secretion patterns and roles of cardiac and circulating arginine vasopressin during the development of heart failure.

  2015cited by this paper
• Emerging role of neurotensin in regulation of the cardiovascular system.

  2015cited by this paper
• Neuropeptide Y damages the integrity of mitochondrial structure and disrupts energy metabolism in cultured neonatal rat cardiomyocytes.

  2015cited by this paper
• Effects of the Galanin Receptor Antagonist M40 on Cardiac Function and Remodeling in Rats with Heart Failure.

  2015cited by this paper
• Substance P induces cardioprotection in ischemia-reperfusion via activation of AKT.

  2015cited by this paper
• Remodeling of stellate ganglion neurons after spatially targeted myocardial infarction: Neuropeptide and morphologic changes.

  2015cited by this paper
• Atrial sympathetic remodeling in experimental hyperthyroidism and hypothyroidism rats.

  2015cited by this paper
• EGFR-TKI, Erlotinib, Causes Hypomagnesemia, Oxidative Stress, and Cardiac Dysfunction: Attenuation by NK-1 Receptor Blockade

  2015cited by this paper
• Central injection of GalR1 agonist M617 facilitates GLUT4 expression in cardiac muscle of type 2 diabetic rats.

  2015cited by this paper
• Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues

  2015cited by this paper
• Non-human primate and rat cardiac fibroblasts show similar extracellular matrix-related and cellular adhesion gene responses to substance P.

  2015cited by this paper
• Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

  2014cited by this paper
• Pro-substance p for evaluation of risk in acute myocardial infarction.

  2014cited by this paper
• Catestatin Increases the Expression of Anti-Apoptotic and Pro-Angiogenetic Factors in the Post-Ischemic Hypertrophied Heart of SHR

  2014cited by this paper
• Autoimmunity and pulmonary hypertension in patients with Graves’ disease

  2014cited by this paper
• Increased vasopressin 1A receptor expression in failing human hearts.

  2014cited by this paper
• Substance P in heart failure: the good and the bad.

  2014cited by this paper
• Calcitonin gene-related peptide: physiology and pathophysiology.

  2014cited by this paper
• Cardio-vascular activity of catestatin: interlocking the puzzle pieces.

  2014cited by this paper
• Effect of endogenous galanin on glucose transporter 4 expression in cardiac muscle of type 2 diabetic rats.

  2014cited by this paper
• Gene Deletion of VIP Leads to Increased Mortality Associated with Progressive Right Ventricular Hypertrophy.

  2014cited by this paper
• Local infiltration of neuropeptide Y as a potential therapeutic agent against apoptosis and fibrosis in a swine model of hypercholesterolemia and chronic myocardial ischemia.

  2013cited by this paper
• Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction

  2013cited by this paper
• Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension.

  2013cited by this paper
• Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.

  2013cited by this paper
• VIP Gene Deletion in Mice Causes Cardiomyopathy Associated with Upregulation of Heart Failure Genes

  2013cited by this paper
• Galanin participates in the functional regulation of the diabetic heart.

  2013cited by this paper
• Ang II receptor expression and effect of Ang II receptor blockade in thyrotoxic rat myocardium.

  2013cited by this paper
• Safety of neurokinin-1 receptor antagonists

  2013cited by this paper
• Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia.

  2012cited by this paper
• Neuropeptide Signaling Activates Dendritic Cell-Mediated Type 1 Immune Responses through Neurokinin-2 Receptor

  2012cited by this paper
• Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?

  2012cited by this paper
• Parasympathetic and substance P-immunoreactive nerve denervation in atrial fibrillation models.

  2012cited by this paper
• Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties

  2012cited by this paper
• The EGFR tyrosine kinase inhibitor tyrphostin AG-1478 causes hypomagnesemia and cardiac dysfunction.

  2012cited by this paper
• The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: Implications for neural control of cardiac excitability

  2012cited by this paper
• Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.

  2012cited by this paper
• The Angiogenic Factor Secretoneurin Induces Coronary Angiogenesis in a Model of Myocardial Infarction by Stimulation of Vascular Endothelial Growth Factor Signaling in Endothelial Cells

  2012cited by this paper
• Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P.

  2011cited by this paper
• Immunohistochemical characterization of the intrinsic cardiac neural plexus in whole-mount mouse heart preparations.

  2011cited by this paper
• Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.

  2011cited by this paper
• Loss of neutral endopeptidase activity contributes to neutrophil activation and cardiac dysfunction during chronic hypomagnesemia: Protection by substance P receptor blockade.

  2011cited by this paper
• Neuropeptide Y-induced coronary microvascular dysfunction: a significant contributor to the adverse outcomes in stress cardiomyopathy?

  2011cited by this paper
• Secretoneurin facilitates endothelium-dependent relaxations in porcine coronary arteries.

  2011cited by this paper
• Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation.

  2011cited by this paper
• Elevated serum levels of neuropeptide Y in stress cardiomyopathy.

  2011cited by this paper
• Calcitonin gene-related peptide suppresses isoprenaline-induced cardiomyocyte apoptosis through regulation of microRNA-1 and microRNA-133a expression.

  2011cited by this paper
• Tryptase/Protease-Activated Receptor 2 Interactions Induce Selective Mitogen-Activated Protein Kinase Signaling and Collagen Synthesis by Cardiac Fibroblasts

  2011cited by this paper
• Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

  2011cited by this paper
• Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms.

  2011cited by this paper
• Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue.

  2011cited by this paper
• Expression of Neuropeptide Y, Substance P, and Their Receptors in the Right Atrium of Diabetic Patients

  2011cited by this paper
• Plasma neuropeptide Y levels differ in distinct diabetic conditions.

  2010cited by this paper
• The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence

  2010cited by this paper
• Effects of somatostatin analogues on acromegalic cardiomyopathy: Results from a prospective study using cardiac magnetic resonance

  2010cited by this paper
• Role of urotensin II in health and disease.

  2010cited by this paper
• Reversal of isoprenaline-induced cardiac remodeling by rutaecarpine via stimulation of calcitonin gene-related peptide production.

  2010cited by this paper
• Neurokinin 1 receptor isoforms and the control of innate immunity.

  2009cited by this paper
• Substance P is required for the pathogenesis of EMCV infection in mice.

  2009cited by this paper
• Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure

  2009cited by this paper
• Cardiac Mast Cells Mediate Left Ventricular Fibrosis in the Hypertensive Rat Heart

  2009cited by this paper
• Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy.

  2008cited by this paper
• Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem?

  2008cited by this paper
• Neurokinin 2 receptor‐mediated activation of protein kinase C modulates capsaicin responses in DRG neurons from adult rats

  2008cited by this paper
• C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.

  2008cited by this paper
• Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.

  2008cited by this paper
• Vasopressin-receptor antagonists in heart failure.

  2008cited by this paper
• The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism.

  2008cited by this paper
• Deletion of the mouse alpha-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury.

  2008cited by this paper
• Involvement of the Neurokinin-2 Receptor in Airway Smooth Muscle Stretch-Activated Contractions Assessed in Perfused Intact Bovine Bronchial Segments

  2008cited by this paper
• Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5.

  2008cited by this paper
• Resident cardiac mast cells: are they the major culprit in the pathogenesis of cardiac hypertrophy?

  2007cited by this paper
• Do cardiac neuropeptides play a role in the occurrence of atrial fibrillation after coronary bypass surgery?

  2007cited by this paper
• NPY and cardiac diseases.

  2007cited by this paper
• Neurokinin-2 Receptor Levels Correlate With Intensity, Frequency, and Duration of Pain in Chronic Pancreatitis

  2007cited by this paper
• Increased neurokinin‐2 receptor expression in alveolar macrophages of smokers with COPD

  2007cited by this paper
• Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure.

  2007cited by this paper
• Effects of neuropeptide Y2 receptor blockade on ventricular arrhythmias in rats with acute myocardial infarction.

  2007cited by this paper
• TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice.

  2007cited by this paper
• SUBSTANCE P IS ASSOCIATED WITH HEART ENLARGEMENT AND APOPTOSIS IN MURINE DILATED CARDIOMYOPATHY INDUCED BY TAENIA CRASSICEPS INFECTION

  2007cited by this paper
• Thyroid disease and the heart.

  2007cited by this paper
• Neurotensin-Induced Myocardial Noradrenergic Effects in Spontaneously Hypertensive Rats

  2006cited by this paper
• Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart.

  2006cited by this paper
• Impact of chronic beta-adrenoceptor activation on neurotensin-induced myocardial effects in rats.

  2006cited by this paper

• Integrated MicroRNA–mRNA Sequencing Analysis Identifies Regulators and Networks Involved in Feline Hypertrophic Cardiomyopathy

  2025cites this paper
• Potential Biomarker and Therapeutic Tools for Pathological Cardiac Hypertrophy and Heart Failure: Extracellular Vesicles

  2025cites this paper
• Neurokinin-1 Receptor Regulation of Fibroblast Phenotype and Function

  2025cites this paper
• Autonomic Imbalance in Cardiomyopathy and Heart Failure: From Neurobiology to Precision Neuromodulation

  2025cites this paper
• On Neurocardiology Updates: an Interdisciplinary Field at the Intersection of Neurology and Cardiology

  2025cites this paper
• Plasma Somatostatin Levels Are Lower in Patients with Coronary Stenosis and Significantly Increase after Stent Implantation

  2024cites this paper
• Computational approaches for identifying neuropeptides: A comprehensive review

  2024cites this paper
• Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside—Part 1

  2024cites this paper
• Neurotensin modulation of inflammation: an update

  2023cites this paper
• Farrerol prevents Angiotensin II-induced cardiac remodeling in vivo and in vitro

  2023cites this paper
• Exploration of Mechanisms of Sacubitril/Valsartan in the Treatment of Cardiac Arrhythmias Using a Network Pharmacology Approach

  2022cites this paper
• Saxagliptin Cardiotoxicity in Chronic Heart Failure: The Role of DPP4 in the Regulation of Neuropeptide Tone

  2022cites this paper
• Dissecting the cellular landscape and transcriptome network in viral myocarditis by single-cell RNA sequencing

  2021cites this paper
• Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective

  2021cites this paper
• The Role of Neuro-Cardiac Junctions in Sympathetic Regulation of the Heart

  2021cites this paper
• Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review.

  2020cites this paper
• Octreotide (somatostatin analog) attenuates cardiac ischemia/reperfusion injury via activating nuclear factor (erythroid-derived 2)-like 2 (Nrf2) signaling pathway in rat model of hyperthyroidism

  2020cites this paper
• Neuropeptide signalling systems -an underexplored target for venom drug discovery.

  2020cites this paper
• Neurogenic inflammation in fulminant myocarditis: May be a trigger.

  2020cites this paper
• Effects of ET-1 and TNF-α levels on the cardiac function and prognosis in rats with chronic heart failure.

  2019cites this paper
• Substance P-mediated cardiac mast cell activation: An in vitro study.

  2019cites this paper
• EFFECTS OF SOMATOSTATIN ANALOGUE (OCTREOTIDE) ON ISCHEMIA–REPERFUSION INJURY IN ADULT HYPERTHYROID ALBINO RATS

  2018cites this paper
• The Role of Neuropeptide Y in Cardiovascular Health and Disease

  2018cites this paper
• Exosomes as New Intercellular Mediators in Development and Therapeutics of Cardiomyocyte Hypertrophy.

  2017cites this paper